HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD (China) holds 13 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 14 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd

Overview

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 18 active FDA Type II Drug Master Files, covering 5-METHOXYURIDINE-5'-TRIPHOSPHATE TRISODIUM SALT; ACARBOSE USP; CAP-2 (7413 SODIUM); DAPTOMYCIN; FONDAPARINUX SODIUM; INSULIN ASPART.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD holds 13 active (17 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • INSULIN ASPARTActive2026-01-29
  • INSULIN DEGLUDECActive2025-09-30
  • VOCLOSPORINActive2025-09-26
  • CAP-2 (7413 SODIUM)Active2023-08-29
  • 5-METHOXYURIDINE-5'-TRIPHOSPHATE TRISODIUM SALTActive2023-08-25
  • SEMAGLUTIDEActive2023-07-19
  • FONDAPARINUX SODIUMActive2020-04-29
  • DAPTOMYCINActive2019-09-25
  • FONDAPARINUX SODIUMActive2014-08-26
  • PANTOPRAZOLE SODIUMActive2011-11-10
  • MUPIROCIN CALCIUMActive2011-03-08
  • POLYMYXIN B SULFATEActive2008-10-01
  • MUPIROCIN (NON-STERILE BULK FORM)Active2007-08-10
  • SIROLIMUSInactive2009-09-14
  • MYCOPHENOLIC ACIDInactive2009-08-24
  • ACARBOSEInactive2005-02-24
  • CLINDAMYCIN PHOSPHATE USPInactive2003-12-23

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.